Pfizer Inc the world's top drug maker, and French firm Sanofi-Aventis are in the race to buy a stake in Indian Wockhardt Ltd's biotechnology business,
The biotechnology business of Wockhardt could be worth 2.5 billion rupees ($48 million) according to analysts
Wockhardt, a mid-sized drug maker, needs about $100 million to repay debt it raised through foreign bonds that expire in Septembe
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment